Insulin-like growth factor-1 levels contribute to the development of bacterial translocation in sepsis

American Journal of Respiratory and Critical Care Medicine

Volumn 182, Issue 4, 2010, Pages 518-525

  Hunninghake, Gary W ^a,b   Doerschug, Kevin C ^a   Nymon, Amanda B ^a   Schmidt, Gregory A ^a   Meyerholz, David K ^a   Ashare, Alix ^a  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Bacteria; Bacterial translocation; Insulin like growth factor 1; Sepsis

Indexed keywords

SOMATOMEDIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BACTEREMIA; BACTERIAL TRANSLOCATION; BLOOD CULTURE; C57BL 6 MOUSE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ENTEROBACTERIACEAE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; ESCHERICHIA COLI; FEMALE; GASTROINTESTINAL TRACT; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE INFECTION; MALE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSEUDOMONAS AERUGINOSA; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEPSIS; ANALYSIS OF VARIANCE; ANIMAL; BLOOD; C57BL MOUSE; DISEASE MODEL; INTESTINE CELL; INTESTINE MUCOSA; METABOLISM; METHODOLOGY; MICROBIOLOGY; MIDDLE AGED; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; BACTERIAL TRANSLOCATION; DISEASE MODELS, ANIMAL; ENTEROCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTESTINAL MUCOSA; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEPSIS;

EID: 77957041861     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200911-1757OC     Document Type: Article

References (51)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the united states: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-1310.
2. Swank GM, Deitch EA. Role of the gut in multiple organ failure: bacterial translocation and permeability changes. World J Surg 1996;20:411-417.
3. Gutierrez G, Palizas F, Doglio G, Wainsztein N, Gallesio A, Pacin J, Dubin A, Schiavi E, Jorge M, Pusajo J, et al. Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients. Lancet 1992;339:195-199.
4. Maynard N, Bihari D, Beale R, Smithies M, Baldock G, Mason R, McColl I. Assessment of splanchnic oxygenation by gastric tonometry in patients with acute circulatory failure. JAMA 1993;270:1203-1210.
5. Karimova A, Pinsky DJ. The endothelial response to oxygen deprivation: biology and clinical implications. Intensive Care Med 2001;27:19-31. (Pubitemid 32208964)
6. Xu DZ, Lu Q, Deitch EA. Nitric oxide directly impairs intestinal barrier function. Shock 2002;17:139-145.
7. Johnston JD, Harvey CJ, Menzies IS, Treacher DF. Gastrointestinal permeability and absorptive capacity in sepsis. Crit Care Med 1996;24:1144-1149.
8. Yu P, Martin CM. Increased gut permeability and bacterial translocation in Pseudomonas pneumonia-induced sepsis. Crit Care Med 2000;28:2573-2577.
9. Coopersmith CM, Stromberg PE, Dunne WM, Davis CG, Amiot DM II, Buchman TG, Karl IE, Hotchkiss RS. Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis. JAMA 2002;287:1716-1721.
10. Doig CJ, Sutherland LR, Sandham JD, Fick GH, Verhoef M, Meddings JB. Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. Am J Respir Crit Care Med 1998;158:444-451. (Pubitemid 28378171)
11. Macintire DK, Bellhorn TL. Bacterial translocation: clinical implications and prevention. Vet Clin North Am Small Anim Pract 2002;32:1165-1178.
12. Frances R, Benlloch S, Zapater P, Gonzalez JM, Lozano B, Munoz C, Pascual S, Casellas JA, Uceda F, Palazon JM, et al. A sequential study of serum bacterial DNA in patients with advanced cirrhosis and ascites. Hepatology 2004;39:484-491.
13. Kane TD, Alexander JW, Johannigman JA. The detection of microbial DNA in the blood: a sensitive method for diagnosing bacteremia and/or bacterial translocation in surgical patients. Ann Surg 1998;227:1-9.
14. Zhang WZ, Han TQ, Tang YQ, Zhang SD. Rapid detection of sepsis complicating acute necrotizing pancreatitis using polymerase chain reaction. World J Gastroenterol 2001;7:289-292.
15. Fazal N, Shamim M, Khan SS, Gamelli RL, Sayeed MM. Neutrophil depletion in rats reduces burn-injury induced intestinal bacterial translocation. Crit Care Med 2000;28:1550-1555.
16. Ashare A, Nymon AB, Doerschug KC, Morrison JM, Monick MM, Hunninghake GW. Insulin-like growth factor-1 improves survival in sepsis via enhanced hepatic bacterial clearance. Am J Respir Crit Care Med 2008;178:149-157.
17. Ashare A, Doerschug KC, Nymon AB, Monick MM, Schmidt GA, Hunninghake GW. Low levels of IGF-1 correlate with the development of bacterial translocation in sepsis [abstract]. Am J Respir Crit Care Med 2009;179:A1147.
18. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: the ACCP/SCCM consensus conference committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644-1655.
19. Ashare A, Monick MM, Powers LS, Yarovinsky T, Hunninghake GW. Severe bacteremia results in a loss of hepatic bacterial clearance. Am J Respir Crit Care Med 2006;173:644-652. (Pubitemid 43363806)
20. Humlicek AL, Pang L, Look DC. Modulation of airway inflammation and bacterial clearance by epithelial cell ICAM-1. Am J Physiol Lung Cell Mol Physiol 2004;287:L598-L607.
21. Bayardelle P, Zafarullah M. Development of oligonucleotide primers for the specific pcr-based detection of the most frequent Enterobacteriaceae species DNA using wec gene templates. Can J Microbiol 2002;48:113-122.
22. Meyerholz DK, Samuel I. Morphologic characterization of early ligation-induced acute pancreatitis in rats. Am J Surg 2007;194:652-658.
23. Dassie JP, Liu XY, Thomas GS, Whitaker RM, Thiel KW, Stockdale KR, Meyerholz DK, McCaffrey AP, McNamara JO II, Giangrande PH. Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors. Nat Biotechnol 2009;27:839-849.
24. Xu D, Qi L, Guillory D, Cruz N, Berg R, Deitch EA. Mechanisms of endotoxin-induced intestinal injury in a hyperdynamic model of sepsis. J Trauma 1993;34:676-682; discussion 682-673.
25. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA 1995;273:117-123.
26. Fink MP. Gastrointestinal mucosal injury in experimental models of shock, trauma, and sepsis. Crit Care Med 1991;19:627-641.
27. Ryan CM, Yarmush ML, Burke JF, Tompkins RG. Increased gut permeability early after burns correlates with the extent of burn injury. Crit Care Med 1992;20:1508-1512.
28. Ziegler TR, Smith RJ, O'Dwyer ST, Demling RH, Wilmore DW. Increased intestinal permeability associated with infection in burn patients. Arch Surg 1988;123:1313-1319.
29. Desai MH, Herndon DN, Rutan RL, Abston S, Linares HA. Ischemic intestinal complications in patients with burns. Surg Gynecol Obstet 1991;172:257-261.
30. Sir O, Fazal N, Choudhry MA, Gamelli RL, Sayeed MM. Neutrophil depletion prevents intestinal mucosal permeability alterations in burn-injured rats. Am J Physiol Regul Integr Comp Physiol 2000;278:R1224-R1231. (Pubitemid 30366451)
31. Cursons RT, Jeyerajah E, Sleigh JW. The use of polymerase chain reaction to detect septicemia in critically ill patients. Crit Care Med 1999;27:937-940.
32. Ashare A, Powers LS, Butler NS, Doerschug KC, Monick MM, Hunninghake GW. Anti-inflammatory response is associated with mortality and severity of infection in sepsis. Am J Physiol Lung Cell Mol Physiol 2005;288:L633-L640.
33. Aronson MD, Bor DH. Blood cultures. Ann Intern Med 1987;106:246-253.
34. Heemskerk VH, Daemen MA, Buurman WA. Insulin-like growth factor-1 (IGF-1) and growth hormone (GH) in immunity and inflammation. Cytokine Growth Factor Rev 1999;10:5-14.
35. Karinch AM, Pan M, Lin CM, Strange R, Souba WW. Glutamine metabolism in sepsis and infection. J Nutr 2001;131:2535S-2538S; discussion 2550S-2551S.
36. Timmins AC, Cotterill AM, Hughes SC, Holly JM, Ross RJ, Blum W, Hinds CJ. Critical illness is associated with low circulating concentrations of insulin-like growth factors-I and -II, alterations in insulin-like growth factor binding proteins, and induction of an insulin-like growth factor binding protein 3 protease. Crit Care Med 1996;24:1460-1466.
37. Muta K, Krantz SB. Apoptosis of human erythroid colony-forming cells is decreased by stem cell factor and insulin-like growth factor I as well as erythropoietin. J Cell Physiol 1993;156:264-271. (Pubitemid 23244088)
38. Jung Y, Miura M, Yuan J. Suppression of interleukin-1 beta-converting enzyme-mediated cell death by insulin-like growth factor. J Biol Chem 1996;271:5112-5117.
39. Matthews CC, Feldman EL. Insulin-like growth factor I rescues SH-SY5Y human neuroblastoma cells from hyperosmotic induced programmed cell death. J Cell Physiol 1996;166:323-331.
40. Petley T, Graff K, Jiang W, Yang H, Florini J. Variation among cell types in the signaling pathways by which IGF-I stimulates specific cellular responses. Horm Metab Res 1999;31:70-76.
41. Dolcet X, Egea J, Soler RM, Martin-Zanca D, Comella JX. Activation of phosphatidylinositol 3-kinase, but not extracellular-regulated kinases, is necessary to mediate brain-derived neurotrophic factor-induced motoneuron survival. J Neurochem 1999;73:521-531.
42. Fukushima R, Saito H, Inoue T, Fukatsu K, Inaba T, Han I, Furukawa S, Lin MT, Muto T. Prophylactic treatment with growth hormone and insulin-like growth factor i improve systemic bacterial clearance and survival in a murine model of burn-induced gut-derived sepsis. Burns 1999;25:425-430.
43. Scopa CD, Koureleas S, Tsamandas AC, Spiliopoulou I, Alexandrides T, Filos KS, Vagianos CE. Beneficial effects of growth hormone and insulin-like growth factor I on intestinal bacterial translocation, endotoxemia, and apoptosis in experimentally jaundiced rats. J Am Coll Surg 2000;190:423-431.
44. Jeschke MG, Bolder U, Chung DH, Przkora R, Mueller U, Thompson JC, Wolf SE, Herndon DN. Gut mucosal homeostasis and cellular mediators after severe thermal trauma and the effect of insulin-like growth factor-I in combination with insulin-like growth factor binding protein-3. Endocrinology 2007;148:354-362.
45. Langouche L, Vanhorebeek I, Vlasselaers D, Vander Perre S, Wouters PJ, Skogstrand K, Hansen TK, Van den Berghe G. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 2005;115:2277-2286.
46. Vanhorebeek I, De Vos R, Mesotten D, Wouters PJ, De Wolf-Peeters C, Van den Berghe G. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 2005;365:53-59.
47. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359-1367.
48. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125-139.
49. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283-1297.
50. Preiser JC, Devos P, Ruiz-Santana S, Melot C, Annane D, Groeneveld J, Iapichino G, Leverve X, Nitenberg G, Singer P, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the glucontrol study. Intensive Care Med 2009;35:1738-1748.
51. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354:449-461.